Drug name - Kerendia

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8436180 BAYER HLTHCARE Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
Apr, 2029

(6 years from now)

CN101641352A BAYER HLTHCARE Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof
Feb, 2028

(5 years from now)

CN101641352B BAYER HLTHCARE Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof
Feb, 2028

(5 years from now)

IN200904992P1 BAYER HLTHCARE Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridine Amides And Their Use
Feb, 2028

(5 years from now)

IN300241B BAYER HLTHCARE Substituted 4-Aryl-1, 4-Dihydro-1, 6-Naphthyridine Compound Of Formula (I)
Feb, 2028

(5 years from now)

EP2132206B1 BAYER HLTHCARE Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof
Feb, 2028

(5 years from now)

EP2132206A2 BAYER HLTHCARE Substituted 4-Aryl-1,4-Dihydro-1,6-Naphthyridinamides And Use Thereof
Feb, 2028

(5 years from now)

Drugs and Companies using FINERENONE ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
10MG TABLET;ORAL Prescription
20MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.